Well boys... I've joined the Master Race Finasteride/Dutasteride 3/17/2026
Finasteride has been effective for maintaining hair density, but due to a slight dip in temple hair, the user switched to dutasteride as an additional measure. Users discuss varying experiences with side effects from finasteride, dutasteride, and minoxidil, highlighting that reactions can differ significantly among individuals.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Misconception: Dutasteride + Minoxidil won't magically regrow your hairline
Dutasteride and minoxidil are more effective at increasing overall hair density rather than regrowing a receded hairline. Some users report success with finasteride and minoxidil for temple regrowth, but results vary.
community Dutasteride 0.5mg 6 months +oral minoxidil 2.5mg
Dutasteride 0.5mg and oral minoxidil 2.5mg improved hair density but not receded temples. No side effects were reported, and the user switched from finasteride to dutasteride due to side effects.
community Can you get hair transplants for frontal temple density ? Or would i be more likely to get shock loss
The user is considering a hair transplant for frontal temple density but is concerned about shock loss. They have been using finasteride for about two years and are advised to consider minoxidil and microneedling for better results.
community Switched from FIN to DUT, hairline/temples worse
Switching from finasteride to dutasteride and oral minoxidil worsened hair thinning at the hairline and temples. The user is considering returning to finasteride, as dutasteride may not be effective for them.
community 1.4 years on finasteride, only lately have signs of improvement been showing
The user noticed hair density improvement after 1.4 years on finasteride, with additional use of minoxidil on the temples. Other users discussed various treatments like dutasteride, estrogen, and hair transplants, sharing personal experiences and advice.
community people who grew hair in temples please help me
Regrowing hair in temple areas is challenging, but some have seen success using treatments like minoxidil, finasteride, and dutasteride, often combined with other methods like scalp massage and low-level laser therapy. Younger individuals may have a better chance of regrowth, but results vary greatly among individuals.
Related Research
6 / 6 results
research Hair Restoration—Nonsurgical and Surgical Approaches
Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.
research Additive Effects of Platelet-Rich Plasma and Systemic Therapies in Androgenetic Alopecia: A Retrospective Study
This study found that combining platelet-rich plasma with systemic therapies for androgenetic alopecia may result in greater improvements in hair density and width than using PRP alone, though the differences were not statistically significant.
research Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
This review discusses the evaluation and management of male baldness and related conditions, but reports no new clinical results.
research Interventions for female pattern hair loss
This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
research Updates in Treatment for Androgenetic Alopecia
This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.
research Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.